跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sodium Bicarbonate 8.4% 4.2 g/50 mL Injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
Sodium Bicarbonate 8.4% 4.2 g/50 mL Injection vial
Approved
STANDARD
Sodium Bicarbonate 8.4% 4.2 g/50 mL Injection vial
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
fa0ab0d98b7441bc
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
fa0ab0d98b7441bc
Product Name
Sodium Bicarbonate 8.4% 4.2 g/50 mL Injection vial
Artg Id
294165
Artg Name
Sodium Bicarbonate 8.4% 4.2 g/50 mL Injection vial
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
2017-09-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
fa0ab0d98b7441bc
Type
Standard
Back to TGA Approvals
